GRANT=6423578;P01AG This application seeks renewed support for the Program Project in Biomedical Outcomes of Aging. We hypothesize that age-associated growth hormone declines influence cardiac and peripheral muscle function during congestive heart failure compensation. Finally, we hypothesize that age-related decrements in insulin release and action lead to the glucose intolerance of aging. Building on our preliminary observations we have formulated a common hypothesis that trophic factor restoration (employing exogenous agents?GHRH, testosterone, GLP/Exendin) will not only correct the underlying deficiency states but be useful tools to correct the impaired tissue structure or function, and improve the symptoms of functional loss in settings where tissue related illnesses have resulted (CHF, sarcopenia and diabetes mellitus). On a more fundamental level we will explore the mechanisms underlying correction of the """"""""trophic endocrinopathy of aging."""""""" Protein synthesis in the heart, peripheral muscle metabolism, growth factors, and hormonal release and action will all be examined before and after hormonal substitution. Common study designs of hormone replacement protocols will be employed to examine structural and functional changes. The shared resources and scientific collaborations int his renewal encompass data management, common analytical procedures (e.g. radioimmunoassays, body composition analysis) and a supply-purchasing system. The Program Project also forms an excellent forum for training of gerontologic investigators, particularly Ph.D. and M.D. trainees entering our institutional programs. The relocation The relocation of the Program Project to the Massachusetts General Hospital following the Principal Investigator's move and the establishment Medicine Unit at the Massachusetts General Hospital opens and extends collaborations. Our new MGH collaborator is Dr. Laurence Katznelson, Endocrine Division. The extensions are Dr. Joel Habner, collaborator of Drs. Elahi and Minaker for many years,"""""""" and Dr. Ronenn Roubenoff Joseph Kehayias and Ms. Virginia Hughes at the USDA Human Nutrition Research Center on Aging at Tufts University. The significance of each project rests in its contribution to the understanding of physiologic and pathophysiologic mechanisms relevant to the health and the common diseases affecting aging Americans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG000599-21
Application #
6665155
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (O2))
Program Officer
Romashkan, Sergei
Project Start
1977-07-01
Project End
2007-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
21
Fiscal Year
2003
Total Cost
$1,229,534
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Elahi, Dariush; Ruff, Dennis A; Carlson, Olga D et al. (2016) Does GLP-1 suppress its own basal secretion? Endocr Res 41:16-20
Elahi, Dariush; Angeli, Franca S; Vakilipour, Amin et al. (2014) GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs. Peptides 59:20-4
Ahmed, Sofia B; Bentley-Lewis, Rhonda; Hollenberg, Norman K et al. (2009) A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy 28:243-55
Abu-Hamdah, Rania; Rabiee, Atoosa; Meneilly, Graydon S et al. (2009) Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 94:1843-52
Moore, T J; Rich, G; McKnight, J A et al. (1996) Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens 9:54-60
Hollenberg, N K; Moore, T J (1994) Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 42:805-8
Allan, D R; McKnight, J A; Kifor, I et al. (1994) Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
Bauer, K A; Kass, B L; ten Cate, H et al. (1990) Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731-6
Lee, J K; Gordon, P R; Stall, G M et al. (1989) Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line. Metabolism 38:1154-61
Bauer, K A; Weiss, L M; Sparrow, D et al. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 80:1527-34